作为载体介导药物相互作用的内源生物标志物,基氨酸的进展
Pengfei Zhao1, Yin Hu1,2, Xinhua Hu1
1Center of Clinical Pharmacology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Frontiers in pharmacology
|January 22, 2026
概括
甲 (CPs) 作为生物标志物,有望预测通过有机阴离子载体聚 (OATP1B) 介导的药物相互作用. 整合CP与建模可以提高药物开发的安全性和效率.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物标志物发现发现
- 药物开发 药物开发
背景情况:
- 药物相互作用 (DDI) 在药物开发和临床实践中带来了重大挑战.
- 载体蛋白质对药物药理动力学,安全性和组合疗法的疗效具有关键影响.
- 当前体外和体外方法的局限性需要使用替代策略来评估载体介导的DDI.
研究的目的:
- 审查使用共二烯 (CPs) 作为载体介导药物相互作用的内源生物标志物的进展.
- 探索CP与基于模型的技术的整合,用于对OATP1B介导的DDI进行定量预测.
- 确定基于CP的DDI评估的当前挑战和未来方向.
主要方法:
- 对作为生物标志物的共二烯 (CPs) 现有文献的审查.
- 讨论量化预测的基于模型的方法.
- 分析挑战和未来的研究需求.
主要成果:
- 包括CP-I和CP-III在内的CP被确定为OATP1B介导的DDI的有希望的内源生物标志物.
- 将CP与基于模型的技术集成,可以提高对这些相互作用的定量预测.
- 目前的挑战包括未定义的值,疾病影响,以及对亚型选择性生物标志物的需求.
结论:
- 作为OATP1B介导的DDI的内源生物标志物,CP代表了显著的进步.
- 进一步的研究和与先进技术的整合对于监管批准和临床应用至关重要.
- 临床医生有潜力提高药物开发和患者护理的效率和安全性.
相关概念视频
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
5.9K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.9K
Pharmacokinetics: Drug–Drug Interactions
389
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
389
Cellular Membranes and Drug Transport
1.5K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.5K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
222
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
222
Drug-Receptor Interactions
7.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
Factors Affecting Protein-Drug Binding: Drug Interactions
574
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
574


